The application of HER2 and CD47 CAR-macrophage in ovarian cancer
Abstract Background The chimeric antigen receptor (CAR)-T therapy has a limited therapeutic effect on solid tumors owing to the limited CAR-T cell infiltration into solid tumors and the inactivation of CAR-T cells by the immunosuppressive tumor microenvironment. Macrophage is an important component...
Main Authors: | Yizhao Chen, Xiangling Zhu, Hanze Liu, Cunzhi Wang, Yu Chen, Huihui Wang, Yilong Fang, Xuming Wu, Yuting Xu, Chunhua Li, Xinyue Lv, Jinghua Huang, Xintong Han, Ruilin Li, Wenming Hong, Zhiying Yu, Wei Wei, Jiajie Tu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04479-8 |
Similar Items
-
Deciphering the role of CD47 in cancer immunotherapy
by: Yu'e Liu, et al.
Published: (2024-09-01) -
Role of CD47 in Hematological Malignancies
by: Entsar Eladl, et al.
Published: (2020-07-01) -
Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells
by: Rui Zheng, et al.
Published: (2023-11-01) -
The Third Generation Anti-HER2 Chimeric Antigen Receptor Mouse T Cells Alone or Together With Anti-PD1 Antibody Inhibits the Growth of Mouse Breast Tumor Cells Expressing HER2 in vitro and in Immune Competent Mice
by: Panyuan Li, et al.
Published: (2020-07-01) -
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma
by: Catrin Heim, et al.
Published: (2023-08-01)